RxDoctor Payments Data

Oscar Ordonez, MD

Internal Medicine · Parker City, INNPI 1518940196

Payments from drug & device makers

$1,048in general payments, 2019–2025

Across 63 payments — averaging $16.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Supernus Pharmaceuticals, Inc.$414
  • Abbott$325
  • Johnson & Johnson$111
  • Lilly USA, LLC$76
  • Pfizer$70
  • Exact Sciences$18
  • plus $34 from 2 others

What the payments were for

  • Food & beverage$1,048100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,048 in reported general payments places this provider in the 75th percentile of 1,747 internal medicine providers in Indiana.

See all internal medicine providers in Indiana

Medicare billing

Part B allowed, 2024
$152,725
Medicare patients
163
Services billed
1,823

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide34$38,683
EliquisApixaban22$29,645
JardianceEmpagliflozin15$12,723
TrulicityDulaglutide11$12,500
Trelegy ElliptaFluticasone/Umeclidin/Vilanter11$6,839
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen253$5,172
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen108$2,869
Gabapentin222$2,568
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine111$2,554
Amlodipine-OlmesartanAmlodipine Bes/Olmesartan Med29$2,475
Lantus SolostarInsulin Glargine,hum.Rec.Anlog12$1,924
Levothyroxine Sodium159$1,895
Oxycodone Hcl45$1,605
Alprazolam200$1,470
Tamsulosin Hcl79$1,278

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$70$29,64522 claims
Lilly USA, LLCTrulicity$76$12,50011 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,747 internal medicine providers in Indiana.

Other internal medicine in Parker City

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →